
Modified insulin-like growth factor 1 analogue
IGF-1 LR3
Modified insulin-like growth factor 1 analogue. Supplied for laboratory research use only.
- Modified IGF-1 analogue; no published human trials exist
- Distinct from Increlex (mecasermin), an approved but different product
- FDA issued 30+ warning letters naming it, 2017-2022
- Supplied for laboratory research use only. Not for human or veterinary use.
90-Day Money-Back Guarantee
Every order is covered for ninety days from delivery. If you decide against it inside that window, contact us and we will refund the purchase price.
Research use only. Not for human or veterinary use or consumption. This product is not approved by the FDA and is not intended to diagnose, treat, cure or prevent any disease.
What it is
Development status
IGF-1 LR3 is not approved by the FDA for any indication.
Development status is stated above. No efficacy claim is made on this page.
Shipping & returns
The specifics
The details, if you want them.
Development
Where it is up to.
No published human clinical trials of IGF-1 LR3 itself exist; all identified evidence is preclinical.
Questions
The questions people actually ask.
What is IGF-1 LR3?
Is this the same as Increlex?
What does "Research Use Only" mean?
How is IGF-1 LR3 supplied?
What is your refund policy?